ARK Sells Amazon, Buys CoreWeave and Twist Bioscience

it.investing.com (Italian) —

Cathie Wood's ARK ETFs sold Amazon and Palantir shares while buying CoreWeave and Twist Bioscience on Thursday, November 12, 2026, signaling a shift toward AI infrastructure and biotech. ARK purchased 283,022 CoreWeave shares worth $17.2 million and 72,834 Twist Bioscience shares for $8.9 million. It sold 15,941 Amazon shares ($4.2 million) and 58,339 Palantir shares ($10.1 million), continuing recent reductions in both positions. ARK also added to Archer Aviation, Kratos Defense, Rocket Lab, and Scribe Therapeutics, while selling BYD and Tempus AI shares. These trades reflect ongoing portfolio rebalancing toward emerging technologies.


With a significance score of 1.7, this news ranks in the top 29% of today's 31735 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: